REPLIGEN CORP Amortization of Debt Discount (Premium)
REPLIGEN CORP (RGEN) reported Amortization of Debt Discount (Premium) of $8.16 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2025-08-07
- REPLIGEN CORP amortization of debt discount (premium) for the quarter ending 2025-06-30 was $4.12M, a 5.13% increase year-over-year.
- REPLIGEN CORP amortization of debt discount (premium) for the quarter ending 2025-03-31 was $4.04M, a 6.04% increase year-over-year.
- REPLIGEN CORP amortization of debt discount (premium) for the quarter ending 2024-12-31 was $3.96M, a 268.37% increase year-over-year.
- REPLIGEN CORP amortization of debt discount (premium) for the quarter ending 2024-09-30 was $3.90M, a 749.89% increase year-over-year.
- REPLIGEN CORP amortization of debt discount (premium) for fiscal 2024 was $15.59M, a 536.76% increase from fiscal 2023.
- REPLIGEN CORP amortization of debt discount (premium) for fiscal 2023 was $2.45M, a 34.88% increase from fiscal 2022.
- REPLIGEN CORP amortization of debt discount (premium) for fiscal 2022 was $1.81M, a 84.26% decline from fiscal 2021.
- REPLIGEN CORP amortization of debt discount (premium) for fiscal 2021 was $11.53M, a 5.10% increase from fiscal 2020.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2025-06-30 | $4.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $8.16M 10-Q · filed 2025-08-07 | $12.12M derived: sum of 3 quarters · filed 2025-08-07 | $16.02M derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | $4.04M 10-Q · filed 2025-04-29 | $8.00M derived: sum of 2 quarters · filed 2025-04-29 | $11.90M derived: sum of 3 quarters · filed 2025-04-29 | $15.82M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-12-31 | $3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $7.86M derived: sum of 2 quarters · filed 2025-03-14 | $11.78M derived: sum of 3 quarters · filed 2025-08-07 | $15.59M 10-K · filed 2025-03-14 |
| 2024-09-30 | $3.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18 | $7.82M derived: sum of 2 quarters · filed 2025-08-07 | $11.63M 10-Q · filed 2024-11-18 | $12.70M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-06-30 | $3.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $7.73M 10-Q · filed 2025-08-07 | $8.80M derived: sum of 3 quarters · filed 2025-08-07 | $9.26M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $3.81M 10-Q · filed 2025-04-29 | $4.88M derived: sum of 2 quarters · filed 2025-04-29 | $5.34M derived: sum of 3 quarters · filed 2025-04-29 | $5.80M derived: sum of 4 quarters · filed 2025-04-29 |
| 2023-12-31 | $1.07M derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-03-14 | $1.53M derived: sum of 2 quarters · filed 2025-03-14 | $1.99M derived: sum of 3 quarters · filed 2025-03-14 | $2.45M 10-K · filed 2025-03-14 |
| 2023-09-30 | $459.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | $916.00K derived: sum of 2 quarters · filed 2024-11-18 | $1.37M 10-Q/A · filed 2024-11-18 | $1.83M derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-06-30 | $457.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | $914.00K 10-Q/A · filed 2024-11-18 | $1.37M derived: sum of 3 quarters · filed 2025-03-14 | $1.82M derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-03-31 | $457.00K 10-Q/A · filed 2024-11-18 | $912.00K derived: sum of 2 quarters · filed 2025-03-14 | $1.37M derived: sum of 3 quarters · filed 2025-03-14 | $1.82M derived: sum of 4 quarters · filed 2025-03-14 |
| 2022-12-31 | $455.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $910.00K derived: sum of 2 quarters · filed 2025-03-14 | $1.36M derived: sum of 3 quarters · filed 2025-03-14 | $1.81M 10-K · filed 2025-03-14 |
| 2022-09-30 | $455.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $908.00K derived: sum of 2 quarters · filed 2022-11-01 | $1.36M 10-Q · filed 2022-11-01 | $4.30M derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-06-30 | $453.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $905.00K 10-Q · filed 2022-08-02 | $3.84M derived: sum of 3 quarters · filed 2024-11-18 | $6.75M derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-03-31 | $452.00K 10-Q · filed 2022-04-27 | $3.39M derived: sum of 2 quarters · filed 2024-11-18 | $6.29M derived: sum of 3 quarters · filed 2024-11-18 | $9.15M derived: sum of 4 quarters · filed 2024-11-18 |
| 2021-12-31 | $2.94M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18 | $5.84M derived: sum of 2 quarters · filed 2024-11-18 | $8.70M derived: sum of 3 quarters · filed 2024-11-18 | $11.53M 10-K/A · filed 2024-11-18 |
| 2021-09-30 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $5.76M derived: sum of 2 quarters · filed 2022-11-01 | $8.59M 10-Q · filed 2022-11-01 | $11.39M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $2.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $5.69M 10-Q · filed 2022-08-02 | $8.48M derived: sum of 3 quarters · filed 2023-02-22 | $11.24M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $2.83M 10-Q · filed 2022-04-27 | $5.62M derived: sum of 2 quarters · filed 2023-02-22 | $8.38M derived: sum of 3 quarters · filed 2023-02-22 | $11.11M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $5.55M derived: sum of 2 quarters · filed 2023-02-22 | $8.28M derived: sum of 3 quarters · filed 2023-02-22 | $10.97M 10-K · filed 2023-02-22 |
| 2020-09-30 | $2.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $5.48M derived: sum of 2 quarters · filed 2021-10-28 | $8.18M 10-Q · filed 2021-10-28 | $10.85M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | $2.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | $5.42M 10-Q · filed 2021-07-27 | $8.09M derived: sum of 3 quarters · filed 2022-02-17 | $10.72M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | $2.69M 10-Q · filed 2021-05-04 | $5.36M derived: sum of 2 quarters · filed 2022-02-17 | $8.00M derived: sum of 3 quarters · filed 2022-02-17 | $9.12M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $5.30M derived: sum of 2 quarters · filed 2022-02-17 | $6.43M derived: sum of 3 quarters · filed 2022-02-17 | $7.54M 10-K · filed 2022-02-17 |
| 2019-09-30 | $2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $3.76M derived: sum of 2 quarters · filed 2020-11-05 | $4.86M 10-Q · filed 2020-11-05 | $5.95M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $2.23M 10-Q · filed 2020-07-30 | $3.32M derived: sum of 3 quarters · filed 2020-07-30 | $4.39M derived: sum of 4 quarters · filed 2020-07-30 |
| 2019-03-31 | $1.11M 10-Q · filed 2020-05-06 | $2.19M derived: sum of 2 quarters · filed 2020-05-06 | $3.27M derived: sum of 3 quarters · filed 2020-05-06 | $4.32M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $2.16M derived: sum of 2 quarters · filed 2020-02-26 | $3.21M derived: sum of 3 quarters · filed 2020-02-26 | $4.25M 10-K · filed 2020-02-26 |
| 2018-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $2.12M derived: sum of 2 quarters · filed 2019-10-31 | $3.16M 10-Q · filed 2019-10-31 | $4.18M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $2.09M 10-Q · filed 2019-08-01 | $3.11M derived: sum of 3 quarters · filed 2020-02-26 | $4.11M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $1.04M 10-Q · filed 2019-05-09 | $2.06M derived: sum of 2 quarters · filed 2020-02-26 | $3.06M derived: sum of 3 quarters · filed 2020-02-26 | $4.04M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $2.02M derived: sum of 2 quarters · filed 2020-02-26 | $3.01M derived: sum of 3 quarters · filed 2020-02-26 | $3.98M 10-K · filed 2020-02-26 |
| 2017-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.99M derived: sum of 2 quarters · filed 2018-11-01 | $2.96M 10-Q · filed 2018-11-01 | $3.91M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $986.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $1.96M 10-Q · filed 2018-08-02 | $2.91M derived: sum of 3 quarters · filed 2019-03-01 | $3.85M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $970.00K 10-Q · filed 2018-05-08 | $1.92M derived: sum of 2 quarters · filed 2019-03-01 | $2.86M derived: sum of 3 quarters · filed 2019-03-01 | |
| 2016-12-31 | $954.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $1.89M derived: sum of 2 quarters · filed 2019-03-01 | $2.27M 10-K · filed 2019-03-01 | |
| 2016-09-30 | $938.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.32M 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $382.00K 10-Q · filed 2017-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |